Iris Diagnostics to Supply Microscopy Technology to LabCorp

Iris Diagnostics (Chatsworth, CA, USA), a division of Iris International, has entered into a five-year agreement to supply and service automated urine microscopy technology for Laboratory Corporation of America (LabCorp, Burlington, NC, USA).

Under the agreement, LabCorp has ordered 26 iQ200 Sprint urine microscopy analyzers from Iris Diagnostics, which will provide training, installation, service, and related reagents and consumables.

"After a comprehensive evaluation process, LabCorp chose our flagship iQ200 Sprint platform, with a throughput of 101 tests per hour and enhanced software that includes digital imaging and auto-particle recognition (APR), which classifies urine particles into 12 categories and quantitatively reports results,” said Dino Alfano, division president, Iris Diagnostics. "Its walk-away convenience in a bench-top system significantly reduces processing time and labor, adding significant value while increasing productivity. We look forward to partnering with LabCorp on this important urinalysis initiative and providing our innovative solution.”

Iris International supplies automated urinalysis technology to major medical institutions throughout the world. The Iris Molecular Diagnostics (IMD) subsidiary develops innovative ultra-sensitive diagnostics and sample-processing products with applications in the urinalysis, oncology, and infectious disease markets.

LabCorp is a large clinical reference laboratory, which operates a nationwide network of 36 primary testing locations and more than 1,300 patient service centers.



Related Links:
Iris Diagnostics
Laboratory Corporation of America